152 related articles for article (PubMed ID: 15569627)
1. Functional protein-protein interaction of drug metabolizing enzymes.
Ishii Y; Takeda S; Yamada H; Oguri K
Front Biosci; 2005 Jan; 10():887-95. PubMed ID: 15569627
[TBL] [Abstract][Full Text] [Related]
2. Interaction between cytochrome P450 and other drug-metabolizing enzymes: evidence for an association of CYP1A1 with microsomal epoxide hydrolase and UDP-glucuronosyltransferase.
Taura KI; Yamada H; Hagino Y; Ishii Y; Mori MA; Oguri K
Biochem Biophys Res Commun; 2000 Jul; 273(3):1048-52. PubMed ID: 10891369
[TBL] [Abstract][Full Text] [Related]
3. Modulation of UDP-glucuronosyltransferase activity by protein-protein association.
Ishii Y; Takeda S; Yamada H
Drug Metab Rev; 2010 Feb; 42(1):145-58. PubMed ID: 19817679
[TBL] [Abstract][Full Text] [Related]
4. Activation of microsomal epoxide hydrolase by interaction with cytochromes P450: kinetic analysis of the association and substrate-specific activation of epoxide hydrolase function.
Taura Ki K; Yamada H; Naito E; Ariyoshi N; Mori Ma MA; Oguri K
Arch Biochem Biophys; 2002 Jun; 402(2):275-80. PubMed ID: 12051674
[TBL] [Abstract][Full Text] [Related]
5. Functional Interaction between Cytochrome P450 and UDP-Glucuronosyltransferase on the Endoplasmic Reticulum Membrane: One of Post-translational Factors Which Possibly Contributes to Their Inter-Individual Differences.
Miyauchi Y; Takechi S; Ishii Y
Biol Pharm Bull; 2021; 44(11):1635-1644. PubMed ID: 34719641
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain.
Ghersi-Egea JF; Perrin R; Leininger-Muller B; Grassiot MC; Jeandel C; Floquet J; Cuny G; Siest G; Minn A
Biochem Pharmacol; 1993 Feb; 45(3):647-58. PubMed ID: 8442765
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
Iyanagi T
Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
[TBL] [Abstract][Full Text] [Related]
8. [Protein-Protein Interactions as Underlying Regulatory Mechanisms of Drug-metabolizing Enzyme Function].
Miyauchi Y
Yakugaku Zasshi; 2022; 142(11):1169-1175. PubMed ID: 36328446
[TBL] [Abstract][Full Text] [Related]
9. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines.
Le HT; Franklin MR
Chem Biol Interact; 1997 Mar; 103(3):167-78. PubMed ID: 9134007
[TBL] [Abstract][Full Text] [Related]
10. Functional co-expression of xenobiotic metabolizing enzymes, rat cytochrome P450 1A1 and UDP-glucuronosyltransferase 1A6, in yeast microsomes.
Ikushiro S; Sahara M; Emi Y; Yabusaki Y; Iyanagi T
Biochim Biophys Acta; 2004 May; 1672(2):86-92. PubMed ID: 15110090
[TBL] [Abstract][Full Text] [Related]
11. Identification of human cytochrome P450 and UGT enzymes involved in the metabolism of ferulic acid, a major bioactive component in traditional Chinese medicines.
Zhuang XM; Chen L; Tan Y; Yang HY; Lu C; Gao Y; Li H
Chin J Nat Med; 2017 Sep; 15(9):695-702. PubMed ID: 28991531
[TBL] [Abstract][Full Text] [Related]
12. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers.
Willey JC; Coy EL; Frampton MW; Torres A; Apostolakos MJ; Hoehn G; Schuermann WH; Thilly WG; Olson DE; Hammersley JR; Crespi CL; Utell MJ
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):114-24. PubMed ID: 9224217
[TBL] [Abstract][Full Text] [Related]
13. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
[TBL] [Abstract][Full Text] [Related]
15. Inducibility of rat brain drug-metabolizing enzymes.
Ghersi-Egea JF; Walther B; Perrin R; Minn A; Siest G
Eur J Drug Metab Pharmacokinet; 1987; 12(4):263-5. PubMed ID: 3130250
[TBL] [Abstract][Full Text] [Related]
16. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation.
Gautier JC; Urban P; Beaune P; Pompon D
Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of human recombinant interleukin-1 beta and dexamethasone on hepatic drug-metabolizing enzymes in male and female rats.
Ferrari L; Herber R; Batt AM; Siest G
Biochem Pharmacol; 1993 Jun; 45(11):2269-77. PubMed ID: 8517867
[TBL] [Abstract][Full Text] [Related]
18. Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes.
Kong TY; Kim JH; Kim DK; Lee HS
Arch Pharm Res; 2018 Jul; 41(7):691-710. PubMed ID: 30039377
[TBL] [Abstract][Full Text] [Related]
19. Correlations of the induction of microsomal epoxide hydrolase activity with phase II drug conjugating enzyme activities in rat liver.
Slawson MH; Franklin MR; Moody DE
Toxicol Lett; 1996 Apr; 85(1):29-34. PubMed ID: 8619256
[TBL] [Abstract][Full Text] [Related]
20. Induction of gene expression of xenobiotic metabolism enzymes and ABC-transport proteins by PAH and a reconstituted PAH mixture in human Caco-2 cells.
Lampen A; Ebert B; Stumkat L; Jacob J; Seidel A
Biochim Biophys Acta; 2004 Nov; 1681(1):38-46. PubMed ID: 15566942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
